Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > BIOMED > 2014 > BW4B > BW4B.2

Pre-treatment total hemoglobin in breast cancer is a predictor for complete response to neoadjuvant chemotherapy

Shudong Jiang, Brian W. Pogue, Jiang Gui, Michael Jermyn, Peter Kaufman, and Keith D. Paulsen

Not Accessible

Your library or personal account may give you access

Abstract

Analysis of NIR tomography imaging of 19 patients undergoing neoadjuvant chemotherapy (NAC) shows pre-treatment tumor HbT values was statistically significant in differentiating the patients with and without complete pathological response (P-value=0.01, AUC=0.92).

© 2014 Optical Society of America

PDF Article
More Like This
Pre-treatment breast MRI and diffuse optical spectroscopic tomography can predict complete response to neoadjuvant chemotherapy

Shudong Jiang, Roberta DeFlorio-Alexander, Jiang Gui, Peter Kaufman, Brian W. Pogue, and Keith D. Paulsen
OTh3C.2 Optical Tomography and Spectroscopy (OT&S) 2016

Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Using Dynamic Tomographic Optical Breast imaging (DTOBI)

Amir Y. Sajjadi, Steven J. Isakoff, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
BW4B.5 Biomedical Optics (BIOMED) 2014

Optical Mammography: Imaging breast cancer response to neoadjuvant chemotherapy

Pamela G. Anderson, Angelo Sassaroli, Sirishma Kalli, Nishanth Krishnamurthy, Shital S. Makim, Roger A. Graham, and Sergio Fantini
TM4B.5 Clinical and Translational Biophotonics (Translational) 2016

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use